Fundamentals of Solid Formulation (FSF2021)

[et_pb_section fb_built=”1″ _builder_version=”4.9.0″ _module_preset=”default”][et_pb_row _builder_version=”4.9.0″ _module_preset=”default”][et_pb_column type=”4_4″ _builder_version=”4.9.0″ _module_preset=”default”][et_pb_image src=”https://lifescienceintegrates.com/wp-content/uploads/2021/03/Webinar-logo.jpeg” _builder_version=”4.9.0″ _module_preset=”default” title_text=”Webinar logo” align=”center” hover_enabled=”0″ sticky_enabled=”0″][/et_pb_image][et_pb_text _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″]

This 7-week webinar series organised by XtalPi and J-STAR starts 7th April 2021.

For busy professionals working in pharmaceutical solid form, we have created a 7-week webinar series to distil state-of-the-art solutions to key challenges. Each webinar will feature a leading expert who understands your daily workflow and will share his/her real-world experience in successfully supporting preclinical and clinical projects.

The series will catalyze discussions aimed at ensuring a stable form is selected with optimal bioavailability and manufacturing properties.

[/et_pb_text][et_pb_divider _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″ custom_padding=”0px||0px||false|false” custom_margin=”0px||0px||false|false”][/et_pb_divider][et_pb_text _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″]

APRIL 7, 2021 Correlation of Drug Substance Bulk Properties to Predict and Troubleshoot the Formulation of Drug Product
Dr. Henry Morrison, Senior Research Scientist II, Gilead Sciences, United States

[/et_pb_text][et_pb_divider _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″ custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false”][/et_pb_divider][et_pb_text _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″]

APRIL 14, 2021 Importance of Solid Form, Formulation and Bioavailability during R&D
Dr. Sudhakar Garad, Global Head of Chemical and Pharmaceutical Profiling, Novartis Institutes for BioMedical Research, United States

[/et_pb_text][et_pb_divider _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″ custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false”][/et_pb_divider][et_pb_text _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″]

APRIL 21, 2021 Solid State Modeling and Its Role in Drug Development
Dr. Luca Iuzzolino, Computational Research Scientist, Merck, United States

[/et_pb_text][et_pb_divider _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″ custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false”][/et_pb_divider][et_pb_text _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″]

APRIL 28, 2021 Amorphous Formulations for Solubility Enhancement: Risks and Opportunities
Dr. Daniel Joseph Price, Strategic Marketing Manager, Millipore Sigma, Germany

[/et_pb_text][et_pb_divider _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″ custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false”][/et_pb_divider][et_pb_text _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″]

MAY 5, 2021 Current Practice and Future Perspective in Crystallography for API Solid Form Risk-Management
Dr. Luca Russo, GSK Fellow, GlaxoSmithKline, United Kingdom

[/et_pb_text][et_pb_divider _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″ custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false”][/et_pb_divider][et_pb_text _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″]

MAY 12, 2021 Application of 15N SSNMR to Differentiate and Quantify Different API Amorphous Phases in Complex Tablet Formulation
Dr. Ales Medek, Research Fellow, Vertex, United States

[/et_pb_text][et_pb_divider _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″ custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false”][/et_pb_divider][et_pb_text _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″]

MAY 19, 2021 Crystallisation in Agrochemicals: the Good, the Bad and the Unusual
Dr. Adam Keates, Specialist Particle Scientist, Syngenta, United Kingdom

[/et_pb_text][et_pb_divider _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″ custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false”][/et_pb_divider][et_pb_text _builder_version=”4.9.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″]

Event Moderator: Dr. Sivakumar Sekharan, Senior Director of Business Development, XtalPi Inc., United States

To register please click here:

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]

Fundamentals of Solid Formulation (FSF2021)